Tenderwize
Zurück zur Suche

Supply of Pharmaceutical Products

МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - БОТЕВГРАД ЕООД·гр. Ботевград, Bulgaria·BGN 566.2k·Deadline Sep 26, 2028 · 763 days left·Restricted·Supplies·DPS
Registrieren zum SpeichernOpen documents
Structured notice only
Originaltitel der Bekanntmachung

Bulgaria – Pharmaceutical products – Динамична система за покупки ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МБАЛ - БОТЕВГРАД“ ЕООД за период от 3 години

40/100

Opportunity Score

Needs reviewMedium complexity
SuppliesDPSOpen
Warum diese Bewertung?

Chance

40 / 100

Komplexität

50 / 100

Risikofaktoren

No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...

Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...

Restricted procedure — pre-qualification required

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • BGN 566.2k estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 36 MONTH
  • Supply of pharmaceutical products (CPV 33600000) to MBAL-Botevgrad Hospital.
  • DPS duration of 36 months.
Vollständige Zusammenfassung anzeigen

This notice establishes a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL-Botevgrad Hospital in Bulgaria for a period of 3 years. The DPS is divided into a single lot covering all pharmaceutical products. The estimated total value is 566,202 BGN. The procedure is restricted, with award based on lowest price. Participation requires a wholesale authorization for medicinal products. The notice publication date is 2025-09-29, and the deadline for admission to the DPS is 2028-09-26. No procurement documents were analyzed.

Risiken

No procurement documents (technical specifications, draft contract, etc.) were provided for analysis. Key details on pr...

Structured data indicates EU funding (isEuFunded: true), but the XML notice states 'no-eu-funds'. This may affect award...

Restricted procedure — pre-qualification required

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must hold a wholesale authorization for medicinal products issued by the Bulgarian Drug Agency or equivalent.

Administrative

  • Must submit an ESPD (European Single Procurement Document) with Part IV, Section A completed.
  • Electronic submission via the CAIS EOP platform is required.

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Lowest price (no weight specified).

Auftraggeber

Ort

гр. Ботевград, BGR

Auftraggeberprofil

Profil öffnen

Kennung

000770022

Tätigkeit

Health

Lose (1)

LOT-0001

Supply of Pharmaceutical Products

Supply of various medicinal products to MBAL-Botevgrad Hospital over a 3-year period. Quantities are indicative and non-binding.

SuppliesDPSEU fundedElectronic submission

BGN 566.2k

Geschätzter Wert

Ort

Ботевград, Bulgaria

Dauer

36 MONTH

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

Frist

Deadline Sep 26, 2028

Vergabedetails

Veröffentlichungsdatum
28 Sep 2025
Sprachen
Bulgarian

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
633535-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3